Mesenchymal stem cell-originated exosomal circDIDO1 suppresses hepatic stellate cell activation by miR-141-3p/PTEN/AKT pathway in human liver fibrosis

The biology <b>,</b> function <b>,</b> and biomedical applications of exosomes

Kalluri, R., & LeBleu, V. S. (2020) · Science · doi:10.1126/science.aau6977 · Cited by 10,770 · see citing works

The biogenesis, biology and characterization of circular RNAs

Kristensen, L. S., Andersen, M. S., Stagsted, L. V. W., Ebbesen, K. K., Hansen, T. B., & Kjems, J. (2019) · Nature Reviews Genetics · doi:10.1038/s41576-019-0158-7 · Cited by 4,823 · see citing works

Mechanisms of hepatic stellate cell activation

Tsuchida, T., & Friedman, S. L. (2017) · Nature Reviews Gastroenterology &amp; Hepatology · doi:10.1038/nrgastro.2017.38 · Cited by 2,909 · see citing works

Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement

Horwitz, E. M., Blanc, K. L., Dominici, M., Mueller, I., Slaper‐Cortenbach, I., Marini, F. C., Deans, R. J., Krause, D. S., & Keating, A. (2005) · Cytotherapy · doi:10.1080/14653240500319234 · Cited by 2,074 · see citing works

The Landscape of Circular RNA in Cancer

Vo, J. N., Cieslik, M. P., Zhang, Y., Shukla, S. K., Xiao, L., Zhang, Y., Wu, Y., Dhanasekaran, S. M., Engelke, C. G., Cao, X., et al. (2019) · Cell · doi:10.1016/j.cell.2018.12.021 · Cited by 1,746 · see citing works

Hepatic stellate cells as key target in liver fibrosis

Higashi, T., Friedman, S. L., & Hoshida, Y. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.05.007 · Cited by 1,485 · see citing works

Using exosomes, naturally-equipped nanocarriers, for drug delivery

Batrakova, E. V., & Kim, M. S. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.07.030 · Cited by 1,122 · see citing works

The PTEN/PI3K/AKT Signalling Pathway in Cancer, Therapeutic Implications

Carnero, A., Blanco‐Aparicio, C., Renner, O., Link, W., & Martínez-Leal, J. F. (2008) · Current Cancer Drug Targets · doi:10.2174/156800908784293659 · Cited by 889 · see citing works

Circular RNA cSMARCA5 inhibits growth and metastasis in hepatocellular carcinoma

Yu, J., Xu, Q., Wang, Z., Yang, Y., Zhang, L., Ma, J., Sun, S., Yang, F., & Zhou, W. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.01.012 · Cited by 763 · see citing works

Concise Review: Multifaceted Characterization of Human Mesenchymal Stem Cells for Use in Regenerative Medicine

Samsonraj, R. M., Raghunath, M., Nurcombe, V., Hui, J. H. P., van Wijnen, A. J., & Cool, S. M. (2017) · Stem Cells Translational Medicine · doi:10.1002/sctm.17-0129 · Cited by 732 · see citing works

Mesenchymal stem cell-derived exosomes as a new therapeutic strategy for liver diseases

Lou, G., Chen, Z., Zheng, M., & Liu, Y. (2017) · Experimental & Molecular Medicine · doi:10.1038/emm.2017.63 · Cited by 605 · see citing works

Liver fibrosis and hepatic stellate cells: Etiology, pathological hallmarks and therapeutic targets

Zhang, C.-Y., Yuan, W.-G., He, P., Lei, J.-H., & Wang, C.-X. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i48.10512 · Cited by 594 · see citing works

Mutant p53 cancers reprogram macrophages to tumor supporting macrophages via exosomal miR-1246

Cooks, T., Pateras, I. S., Jenkins, L. M. M., Patel, K., Robles, A. I., Morris, J., Forshew, T., Appella, E., Gorgoulis, V. G., & Harris, C. C. (2018) · Nature Communications · doi:10.1038/s41467-018-03224-w · Cited by 482 · see citing works

Exosomes: Mediators of Neurodegeneration, Neuroprotection and Therapeutics

Kalani, A., Tyagi, A. A., & Tyagi, N. (2013) · Molecular Neurobiology · doi:10.1007/s12035-013-8544-1 · Cited by 333 · see citing works

Mesenchymal stem cells secretome: a new paradigm for central nervous system regeneration?

Teixeira, F. G., Carvalho, M. M., Sousa, N., & Salgado, A. J. (2013) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1290-8 · Cited by 332 · see citing works

Human bone marrow mesenchymal stem cells-derived exosomes alleviate liver fibrosis through the Wnt/β-catenin pathway

Rong, X., Liu, J., Yao, X., Jiang, T., Wang, Y., & Xie, F. (2019) · Stem Cell Research & Therapy · doi:10.1186/s13287-019-1204-2 · Cited by 322 · see citing works

The Role of Focal Adhesion Kinase-Phosphatidylinositol 3-Kinase-Akt Signaling in Hepatic Stellate Cell Proliferation and Type I Collagen Expression

Reif, S. S., Lang, A., Lindquist, J. N., Yata, Y., Gäbele, E., Scanga, A. E., Brenner, D. A., & Rippe, R. A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212927200 · Cited by 298 · see citing works

Cytotherapy with M1-polarized macrophages ameliorates liver fibrosis by modulating immune microenvironment in mice

Ma, P.-F., Gao, C.-C., Yi, J., Zhao, J.-L., Liang, S.-Q., Zhao, Y., Ye, Y.-C., Bai, J., Zheng, Q.-J., Dou, K.-F., et al. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.05.022 · Cited by 284 · see citing works

Proteomic Analysis of Human Parotid Gland Exosomes by Multidimensional Protein Identification Technology (MudPIT)

González–Begne, M., Lu, B., Han, X., Hagen, F. K., Hand, A. R., Melvin, J. E., & Yates, J. R. (2009) · Journal of Proteome Research · doi:10.1021/pr800658c · Cited by 281 · see citing works

Exosome-transmitted circular RNA hsa_circ_0051443 suppresses hepatocellular carcinoma progression

Chen, W., Quan, Y., Fan, S., Wang, H., Liang, J., Huang, L. T., Chen, L., Liu, Q., He, P., & Ye, Y. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.01.022 · Cited by 268 · see citing works

Macrophage autophagy protects against liver fibrosis in mice

Lodder, J., Denaës, T., Chobert, M.-N., Wan, J., El-Benna, J., Pawlotsky, J.-M., Lotersztajn, S., & Teixeira-Clerc, F. (2015) · Autophagy · doi:10.1080/15548627.2015.1058473 · Cited by 266 · see citing works

MSCs-Derived Exosomes and Neuroinflammation, Neurogenesis and Therapy of Traumatic Brain Injury

Yang, Y., Ye, Y., Su, X., He, J., Bai, W., & He, X. (2017) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2017.00055 · Cited by 236 · see citing works

Emerging Epigenetic Regulation of Circular RNAs in Human Cancer

Wu, J., Qi, X., Liu, L., Hu, X. T., Liu, J., Yang, J., Yang, J., Lu, L., Zhang, Z., Ma, S., et al. (2019) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2019.04.011 · Cited by 222 · see citing works

The decade of exosomal long RNA species: an emerging cancer antagonist

Zhou, R., Chen, K. K., Zhang, J., Xiao, B., Huang, Z., Ju, C., Sun, J., Zhang, F., Lv, X.-B., & Huang, G. (2018) · Molecular Cancer · doi:10.1186/s12943-018-0823-z · Cited by 207 · see citing works

Insights into the regulatory role of circRNA in angiogenesis and clinical implications

Liu, Y., Yang, Y., Wang, Z., Fu, X., Chu, X., Li, Y., Wang, Q., He, X., Li, M., Wang, K., et al. (2020) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2020.02.017 · Cited by 101 · see citing works

Microarray profiling of circular RNAs and the potential regulatory role of hsa_circ_0071410 in the activated human hepatic stellate cell induced by irradiation

Chen, Y., Yuan, B., Wu, Z., Dong, Y., Zhang, L., & Zeng, Z. (2017) · Gene · doi:10.1016/j.gene.2017.07.078 · Cited by 90 · see citing works

Circular RNAs in drug resistant tumors

Hua, X., Sun, Y., Chen, J., Wu, Y., Sha, J., Han, S., & Zhu, X. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.109233 · Cited by 90 · see citing works

CircMTO1 inhibits liver fibrosis via regulation of miR‐17‐5p and Smad7

Wang, W., Dong, R., Guo, Y. G., He, J., Shao, C., Yi, P., Yu, F., Gu, D., & Zheng, J. (2019) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14432 · Cited by 66 · see citing works

Activated hepatic stellate cells impair NK cell anti-fibrosis capacity through a TGF-β-dependent emperipolesis in HBV cirrhotic patients

Shi, J., Zhao, J., Zhang, X., Cheng, Y., Hu, J., Li, Y., Zhao, X., Shang, Q., Sun, Y., Tu, B., et al. (2017) · Scientific Reports · doi:10.1038/srep44544 · Cited by 64 · see citing works

CircRNA ‐0077930 from hyperglycaemia‐stimulated vascular endothelial cell exosomes regulates senescence in vascular smooth muscle cells

Wang, S., Zhan, J., Lin, X., Wang, Y., Wang, Y., & Liu, Y. (2020) · Cell Biochemistry and Function · doi:10.1002/cbf.3543 · Cited by 64 · see citing works

Exosomes derived from circRNA Rtn4-modified BMSCs attenuate TNF-α-induced cytotoxicity and apoptosis in murine MC3T3-E1 cells by sponging miR-146a

Cao, G., Meng, X., Han, X., & Li, J. (2020) · Bioscience Reports · doi:10.1042/bsr20193436 · Cited by 54 · see citing works

MicroRNA-141 Targets Sirt1 and Inhibits Autophagy to Reduce HBV Replication

Yang, Y., Liu, Y., Xue, J., Yang, Z., Shi, Y. H., Shi, Y., Lou, G., Wu, S., Qi, J., Liu, W., et al. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000456162 · Cited by 52 · see citing works

Hsa_circ_0070963 inhibits liver fibrosis via regulation of miR-223-3p and LEMD3

Ji, D., Chen, G., Wang, J., Ji, S., Wu, X., Lu, X., Chen, J., & Li, J.-T. (2020) · Aging · doi:10.18632/aging.102705 · Cited by 45 · see citing works

Activation of hepatic stellate cell in Pten null liver injury model

He, L., Gubbins, J., Peng, Z., Medina, V., Fei, F., Asahina, K., Wang, J., Kahn, M., Rountree, C. B., & Stiles, B. L. (2016) · Fibrogenesis & Tissue Repair · doi:10.1186/s13069-016-0045-1 · Cited by 44 · see citing works

Immunomodulatory effect of human bone marrow‐derived mesenchymal stromal/stem cells on peripheral blood T cells from rheumatoid arthritis patients

Pedrosa, M. F., Gomes, J., Laranjeira, P., Duarte, C. C. M., Pedreiro, S., Antunes, B., Ribeiro, T., dos Santos, F., Martinho, A., Fardilha, M., et al. (2019) · Journal of Tissue Engineering and Regenerative Medicine · doi:10.1002/term.2958 · Cited by 40 · see citing works

PTEN expression is down‐regulated in liver tissues of rats with hepatic fibrosis induced by biliary stenosis

HAO, L. S., Zhang, X. L., AN, J. Y., Karlin, J. N., TIAN, X. P., Dun, Z.-N., XIE, S. R., & CHEN, S. (2009) · Apmis · doi:10.1111/j.1600-0463.2009.02515.x · Cited by 34 · see citing works

hsa_circ_0004018 suppresses the progression of liver fibrosis through regulating the hsa-miR-660-3p/TEP1 axis

Li, S., Song, F., Xu, L., Li, J., Fang, L., & Tan, H. (2020) · Aging · doi:10.18632/aging.103257 · Cited by 32 · see citing works

Downregulation of miR‑141 deactivates hepatic stellate�cells by targeting the PTEN/AKT/mTOR pathway

Liang, H., Wang, X., Si, C., Duan, Y., Chen, B., Liang, H., & Yang, D. (2020) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2020.4578 · Cited by 17 · see citing works

[Progress of the application of stem cell therapy for end-stage liver disease].

Duan, X., Wang, Y., He, J., Peng, Y., Yu, J., & Sun, Y. J. (2017) · PubMed · doi:10.11817/j.issn.1672-7347.2017.04.015 · Cited by 2 · see citing works

Clinical applications of stem cell-derived exosomes

Tan, F., Li, X., Wang, Z., Li, J., Shahzad, K., & Zheng, J. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01704-0 · Cited by 708 · see citing works

Exosomes derived from human adipose mesenchymal stem cells ameliorate hepatic fibrosis by inhibiting PI3K/Akt/mTOR pathway and remodeling choline metabolism

Zhang, Z., Shang, J., Yang, Q., Dai, Z., Liang, Y., Lai, C., Feng, T., Zhong, D., Zou, H., Ji, G., et al. (2023) · Journal of Nanobiotechnology · doi:10.1186/s12951-023-01788-4 · Cited by 125 · see citing works

Liver fibrosis resolution: from molecular mechanisms to therapeutic opportunities

Pei, Q., Yi, Q., & Tang, L. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24119671 · Cited by 121 · see citing works

Mesenchymal stromal cells in hepatic fibrosis/cirrhosis: from pathogenesis to treatment

Yang, X., Li, Q., Liu, W., Zong, C., Wei, L., Shi, Y., & Han, Z. (2023) · Cellular &amp; Molecular Immunology · doi:10.1038/s41423-023-00983-5 · Cited by 120 · see citing works

The potential role and mechanism of circRNA/miRNA axis in cholesterol synthesis

Chen, W., Xu, J., Wu, Y., Liang, B., Yan, M., Sun, C., Wang, D., Hu, X., Liu, L.-Z., Hu, W., et al. (2023) · International Journal of Biological Sciences · doi:10.7150/ijbs.84994 · Cited by 107 · see citing works

Stem cells for treatment of liver fibrosis/cirrhosis: clinical progress and therapeutic potential

Liu, P., Mao, Y., Xie, Y., Wei, J., & Yao, J. (2022) · Stem Cell Research &amp; Therapy · doi:10.1186/s13287-022-03041-5 · Cited by 82 · see citing works

ADSCs-derived exosomes ameliorate hepatic fibrosis by suppressing stellate cell activation and remodeling hepatocellular glutamine synthetase-mediated glutamine and ammonia homeostasis

Wu, B., Feng, J., Guo, J., Wang, J., Xiu, G., Xu, J., Ning, K., Ling, B., Xu, J., & Xu, J. (2022) · Stem Cell Research & Therapy · doi:10.1186/s13287-022-03049-x · Cited by 72 · see citing works

Engineered exosome-mediated delivery of circDIDO1 inhibits gastric cancer progression via regulation of MiR-1307-3p/SOCS2 Axis

Guo, Z., Zhang, Y., Xu, W., Zhang, X., & Jiang, J. (2022) · Journal of Translational Medicine · doi:10.1186/s12967-022-03527-z · Cited by 68 · see citing works

Circular RNAs Acting as miRNAs’ Sponges and Their Roles in Stem Cells

Xiao, J., Joseph, S., Xia, M., Teng, F., Chen, X., Huang, R., Zhai, L., & Deng, W. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11102909 · Cited by 54 · see citing works

Exosomes in liver fibrosis: The role of modulating hepatic stellate cells and immune cells, and prospects for clinical applications

Liu, Y., Zheng, Y., Yang, Y., Liu, K., Wu, J., Gao, P., & Zhang, C. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1133297 · Cited by 53 · see citing works

Macrophage PTEN controls STING-induced inflammation and necroptosis through NICD/NRF2 signaling in APAP-induced liver injury

Yang, T., Qu, X., Zhao, J., Wang, X., Wang, Q., Dai, J., Zhu, C., Li, J., & Jiang, L. (2023) · Cell Communication and Signaling · doi:10.1186/s12964-023-01175-4 · Cited by 53 · see citing works

Signaling pathways activated and regulated by stem cell-derived exosome therapy

Li, D., Li, D., Wang, Z., Li, J., Shahzad, K. A., Wang, Y., & Tan, F. (2024) · Cell & Bioscience · doi:10.1186/s13578-024-01277-7 · Cited by 51 · see citing works

Immunomodulatory and Regenerative Effects of MSC-Derived Extracellular Vesicles to Treat Acute GVHD

Fujii, S., & Miura, Y. (2022) · Stem Cells · doi:10.1093/stmcls/sxac057 · Cited by 47 · see citing works

Current Status and Prospect of Delivery Vehicle Based on Mesenchymal Stem Cell-Derived Exosomes in Liver Diseases

Lu, X., Guo, H., Wei, X., Lu, D., Shu, W., Song, Y., Qiu, N., & Xu, X. (2023) · International Journal of Nanomedicine · doi:10.2147/ijn.s404925 · Cited by 38 · see citing works

Structural and Temporal Dynamics of Mesenchymal Stem Cells in Liver Diseases From 2001 to 2021: A Bibliometric Analysis

Shao, B., Qin, Y., Ren, S., Peng, Q., Qin, H., Wang, Z.-B., Wang, H., Li, G.-M., Zhu, Y., Sun, C.-L., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.859972 · Cited by 36 · see citing works

Mesenchymal Stem Cell-Derived Exosomes: A Promising Therapeutic Agent for the Treatment of Liver Diseases

Ding, Y., Luo, Q., Que, H., Wang, N., Gong, P., & Gu, J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231810972 · Cited by 36 · see citing works

Small-molecule natural plants for reversing liver fibrosis based on modulation of hepatic stellate cells activation: An update

Zheng, Y., Xie, L., Yang, D., Luo, K., & Li, X. (2023) · Phytomedicine · doi:10.1016/j.phymed.2023.154721 · Cited by 32 · see citing works

CircRNAs: versatile players and new targets in organ fibrosis

Wei, L., Liu, L., Bai, M., Ning, X., & Sun, S. (2023) · Cell Communication and Signaling · doi:10.1186/s12964-023-01051-1 · Cited by 30 · see citing works

Eupatilin Ameliorates Hepatic Fibrosis and Hepatic Stellate Cell Activation by Suppressing β-catenin/PAI-1 Pathway

Hu, J., Liu, Y., Pan, Z., Huang, X., Wang, J., Cao, W., & Chen, Z. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065933 · Cited by 29 · see citing works

N6-methyladenosine-modified circIRF2, identified by YTHDF2, suppresses liver fibrosis via facilitating FOXO3 nuclear translocation

Chen, X., Zhu, S., Li, H.-D., Wang, J.-N., Sun, L.-J., Xu, J., Hui, Y.-R., Li, X., Li, L., Zhao, Y.-X., et al. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.125811 · Cited by 28 · see citing works

Mesenchymal stromal/stem cells and their extracellular vesicles in liver diseases: insights on their immunomodulatory roles and clinical applications

Huai, Q., Zhu, C., Zhang, X., Dai, H., Li, X., & Wang, H. (2023) · Cell & Bioscience · doi:10.1186/s13578-023-01122-3 · Cited by 27 · see citing works

Hsa_circ_0073453 modulates IL-8 secretion by GC-MSCs to promote gastric cancer progression by sponging miR-146a-5p

Wu, C., Cao, X., Xu, J., Wang, L., Huang, J., Wen, J., Wang, X., Sang, X., Zhu, W., Yao, Y., et al. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.110121 · Cited by 25 · see citing works

Pharmacological modulation of ferroptosis as a therapeutic target for liver fibrosis

Li, L., & Zhu, Z. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1071844 · Cited by 25 · see citing works

A review of the effect of exosomes from different cells on liver fibrosis

Hu, X., Ge, Q.-L., Zhang, Y., Li, B., Cheng, E., Wang, Y.-H., & Huang, Y. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114415 · Cited by 25 · see citing works

Strategies to improve the therapeutic efficacy of mesenchymal stem cell‐derived extracellular vesicle (MSC-EV): a promising cell-free therapy for liver disease

Zheng, L., Gong, H., Zhang, J., Guo, L., Zhai, Z., Xia, S., Hu, Z., Chang, J., Jiang, Y., Huang, X., et al. (2023) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2023.1322514 · Cited by 25 · see citing works

Mesenchymal Stem Cells and Their Small Extracellular Vesicles as Crucial Immunological Efficacy for Hepatic Diseases

Tang, Y., Wu, P., Li, L., Xu, W., & Jiang, J. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.880523 · Cited by 22 · see citing works

Mesenchymal stem cell-derived exosomes as cell free nanotherapeutics and nanocarriers

Abid, A. I., Conzatti, G., Toti, F., Anton, N., & Vandamme, T. (2024) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2024.102769 · Cited by 22 · see citing works

Circular RNAs with protein-coding ability in oncogenesis

Cheng, J., Li, G., Wang, W., Stovall, D. B., Sui, G., & Li, D. (2023) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2023.188909 · Cited by 21 · see citing works

Role of noncoding RNAs in liver fibrosis

Li, Q., Gong, T., Huang, Y., Kang, L., Warner, C. A., Xie, H., Chen, L., & Duan, X. (2023) · World Journal of Gastroenterology · doi:10.3748/wjg.v29.i9.1446 · Cited by 20 · see citing works

Comparison between the Regenerative and Therapeutic Impacts of Bone Marrow Mesenchymal Stem Cells and Adipose Mesenchymal Stem Cells Pre-Treated with Melatonin on Liver Fibrosis

Elzainy, A., Sadik, A. E., & Altowayan, W. M. (2024) · Biomolecules · doi:10.3390/biom14030297 · Cited by 20 · see citing works

Mesenchymal stem cell-derived exosomes as cell-free therapeutics: mechanistic insights and engineering strategies for liver disease treatment

Yu, S., Kong, D., Lu, B., Pan, Y., Zeng, Z., Fu, Y., Zhao, Z., He, K., Tang, R., & Xia, Q. (2025) · Stem Cell Research & Therapy · doi:10.1186/s13287-025-04747-y · Cited by 22 · see citing works

Proangiogenic role of circRNA ‐007371 in liver fibrosis

Zhao, C., Qian, S., Tai, Y., Guo, Y., Tang, C., Huang, Z., & Gao, J. (2023) · Cell Proliferation · doi:10.1111/cpr.13432 · Cited by 18 · see citing works

Role of extracellular vesicles in nonalcoholic fatty liver disease

Jiang, W., Xu, Y., Chen, J., Lee, Y.-H., Hu, Y., Liu, C.-H., Chen, E.-Q., Tang, H., Zhang, H., & Wu, D. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1196831 · Cited by 18 · see citing works

SPOC domain proteins in health and diseasePreprint

Appel, L.-M., Benedum, J., Engl, M., Platzer, S. W., Schleiffer, A., Strobl, X., & Slade, D. (2023) · Genes & Development · doi:10.1101/gad.350314.122 · Cited by 19 · see citing works

Advances in the treatment of liver injury based on mesenchymal stem cell-derived exosomes

Hu, C., & Wang, L. (2024) · Stem Cell Research & Therapy · doi:10.1186/s13287-024-04087-3 · Cited by 18 · see citing works

Current progress and limitations of research regarding the therapeutic use of adipose-derived stem cells: literature review

Скрипник, М. І. (2024) · Journal of Umm Al-Qura University for Applied Sciences · doi:10.1007/s43994-024-00147-9 · Cited by 16 · see citing works

Novel insights into the role of immunomodulatory extracellular vesicles in the pathogenesis of liver fibrosis

Li, J., Yuan, Y., Fu, Q., Chen, M., Liang, H., Chen, X., Long, X., Zhang, B., Zhao, J., & Chen, Q. (2024) · Biomarker Research · doi:10.1186/s40364-024-00669-8 · Cited by 16 · see citing works

Unraveling the Emerging Niche Role of Hepatic Stellate Cell-derived Exosomes in Liver Diseases

Yin, K.-L., Li, M., Song, P., Duan, Y., Ye, W.-T., Tang, W., Kokudo, N., Gao, Q., & Liao, R. (2022) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2022.00326 · Cited by 15 · see citing works

Single‐cell RNA sequencing reveals reduced intercellular adhesion molecule crosstalk between activated hepatic stellate cells and neutrophils alleviating liver fibrosis in hepatitis B virus transgenic mice post menstrual blood‐derived mesenchymal stem cell transplantation

Chen, L., Huang, Y., Zhang, N., Qu, J., Fang, Y., Fu, J., Yuan, Y., Zhang, Q., Li, H., Wen, Z., et al. (2024) · MedComm · doi:10.1002/mco2.654 · Cited by 15 · see citing works

Overview of CircRNAs Roles and Mechanisms in Liver Fibrosis

Wang, G., Tong, J., Li, Y.-C., Qiu, X., Chen, A., Chang, C., & Yu, G. (2023) · Biomolecules · doi:10.3390/biom13060940 · Cited by 14 · see citing works

Extracellular vesicles: emerging therapeutic agents for liver fibrosis

Chiabotto, G., Semnani, A., Ceccotti, E., & Bruno, S. (2025) · Extracellular Vesicles and Circulating Nucleic Acids · doi:10.20517/evcna.2025.08 · Cited by 13 · see citing works

Exosomal circ-1199 derived from EPCs exposed to oscillating shear stress acts as a sponge of let-7g-5p to promote endothelial-mesenchymal transition of EPCs by increasing HMGA2 expression

Li, L., Wen, J., Li, H., He, Y., Cui, X., Zhang, X., Guan, X., Li, Z., & Cheng, M. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.121223 · Cited by 13 · see citing works

Cell therapy for end-stage liver disease: Current state and clinical challenge

Zhang, L., Deng, Y., Bai, X., Wei, X., Ren, Y., Chen, S., & Deng, H. (2024) · Chinese Medical Journal · doi:10.1097/cm9.0000000000003332 · Cited by 12 · see citing works

Regulatory Functions and Mechanisms of Circular RNAs in Hepatic Stellate Cell Activation and Liver Fibrosis

Nokkeaw, A., Thamjamrassri, P., Tangkijvanich, P., & Ariyachet, C. (2023) · Cells · doi:10.3390/cells12030378 · Cited by 13 · see citing works

microRNAs ‐based diagnostic and therapeutic applications in liver fibrosis

Zhao, X., Xue, X., Cui, Z., Amevor, F. K., Wan, Y., Fu, K., Wang, C., Peng, C. Y., & Li, Y. (2022) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.1773 · Cited by 12 · see citing works

TGFβ1-Pretreated Exosomes of Wharton Jelly Mesenchymal Stem Cell as a Therapeutic Strategy for Improving Liver Fibrosis

Bavarsad, S. S., Jalali, M. T., Nejad, D. B., Alypoor, B., Babaahmadi‐Rezaei, H., & Mohammadtaghvaei, N. (2022) · Hepatitis Monthly · doi:10.5812/hepatmon-123416 · Cited by 11 · see citing works

Targeting MAGI2‐AS3‐modulated Akt‐dependent ATP‐binding cassette transporters as a possible strategy to reverse temozolomide resistance in temozolomide‐resistant glioblastoma cells

Chen, Z., Zhou, J., Liu, Y., Ni, H., & Zhou, B. (2023) · Drug Development Research · doi:10.1002/ddr.22101 · Cited by 9 · see citing works

Extracellular Vesicles from Mesenchymal Stem Cells: Potential as Therapeutics in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

Zou, X., & Brigstock, D. R. (2024) · Biomedicines · doi:10.3390/biomedicines12122848 · Cited by 10 · see citing works

Cutting-edge insights into liver fibrosis: advanced therapeutic strategies and future perspectives using engineered mesenchymal stem cell-derived exosomes

Didamoony, M. A., Soubh, A. A., & Ahmed, L. A. (2025) · Drug Delivery and Translational Research · doi:10.1007/s13346-024-01784-7 · Cited by 9 · see citing works

Hsa_circ_0000081 promotes the function of gastric cancer through sponging hsa-miR-423-5p to influence 3-phosphoinositide-dependent kinase 1 expression

Jiang, F., Hu, X., Cao, H., & Shen, X. (2022) · Bioengineered · doi:10.1080/21655979.2022.2053796 · Cited by 9 · see citing works

Circular RNAs in Cardiovascular Diseases: Molecular Mechanisms, Therapeutic Advances, and Innovations

Yuan, Z., Huang, S., Jin, X. K., & Li, S. (2024) · Genes · doi:10.3390/genes15111423 · Cited by 8 · see citing works

The Role of Extracellular Vesicles in Liver Fibrosis: Friends or Foes?

Tao, X., Chen, C., & Liu, M. (2024) · Biomedicines · doi:10.3390/biomedicines12122665 · Cited by 8 · see citing works

The engineered bone marrow mesenchymal stem cell-derived exosome: A new strategy for the treatment of inflammatory diseases

Peng, X., Cui, H. Z., Tan, S., Wen, B., Luo, X., Chen, S., Luo, J., Zhong, P., Ning, T., & Ma, D. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.115136 · Cited by 8 · see citing works

Investigating the Role of Non-Coding RNA in Non-Alcoholic Fatty Liver Disease

Zailaie, S. A., Khoja, B. B., Siddiqui, J. J., Mawardi, M., Heaphy, E. L. G., Aljagthmi, A. A., & Sergi, C. M. (2024) · Non-Coding RNA · doi:10.3390/ncrna10010010 · Cited by 10 · see citing works

METTL3 Promotes Osteogenic Differentiation of Human Periodontal Ligament Stem Cells Under the Inflammatory Microenvironment Through the miR-141-3p/ZEB1 Axis

Li, W., & Alimujiang, A. (2024) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-024-01586-1 · Cited by 8 · see citing works

Placental homing peptide guides HIF1α‑silenced exosomes conjugates for targeted enhancement of invasion of trophoblast cells

Chen, F., Cen, H., Mao, D., & Feng, R. (2023) · Molecular Medicine Reports · doi:10.3892/mmr.2023.13022 · Cited by 7 · see citing works

Bone marrow mesenchymal stem cell-originated exosomes suppress activation of hepatic stellate cells through the miR-144-3p/SLC7A11 axis

Hao, Y., Wang, R., Zhou, Q., & Ren, J. (2024) · Clinical and Experimental Hepatology · doi:10.5114/ceh.2024.142898 · Cited by 6 · see citing works

ADSCs attenuate Liver fibrosis via inducing HSC senescence: validation in dual-etiology models

Mulati, M., Yang, N., Xue, J., Liang, L., Zhang, X., Liu, H., Chu, J., Lü, G., Kusuman, N., He, X., et al. (2025) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0013094 · Cited by 6 · see citing works

PTEN-mediated senescence of lung epithelial cells drives ventilator-induced pulmonary fibrosis

Li, M., Wang, Y., Hu, Z., Huang, S., Chen, P., Chen, L., Wu, J., Wu, Z., Yao, S., & Yang, Y. (2025) · Theranostics · doi:10.7150/thno.117523 · Cited by 6 · see citing works

Engineered Mesenchymal Stem Cell-Derived Small Extracellular Vesicles Mitigate Liver Fibrosis by Delivering USP10 to Reprogram Macrophage Phenotype

Tian, S., Zhou, X., Zheng, L., Liu, J., Zhang, M., Ma, S., Zheng, X., Guo, G., Ju, R., Yang, F., et al. (2025) · Biomaterials Research · doi:10.34133/bmr.0244 · Cited by 6 · see citing works

miRNAs, lncRNAs, circRNAs and piRNAs in Nonalcoholic Fatty Liver Disease: Past, Present and Future

Lucaciu, R. L., Orasan, O. H., Hangan, A. C., Iancu, M., Cozma, A., Coste, S. C., Gog-Bogdan, S., Sevastre, B., & Procopciuc, L. M. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262110402 · Cited by 7 · see citing works

Mechanisms of Epigenetic Regulation in the Fibrogenic Activation of Hepatic Stellate Cells in Non-alcoholic Fatty Liver Disease

Garbuzenko, D. V. (2024) · Gene Expression · doi:10.14218/ge.2023.00090 · Cited by 6 · see citing works

The roles of epigenetic regulation in graft-versus-host disease

Wang, Y., Liu, Q., Deng, L., Ma, X., Gong, Y., Wang, Y., & Zhou, F. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116652 · Cited by 6 · see citing works

Extracellular Vesicles in Nonalcoholic Fatty Liver Disease: Mechanisms and Therapeutic Opportunities

Dong, Y., Xiong, L., Zhu, N., Wang, Z., Xia, H., Cheng, C., Huang, J., Han, Y., Rahman, A., Zhao, J., et al. (2025) · iNew Medicine · doi:10.1002/inm3.3 · Cited by 5 · see citing works

Research Progress on the Effect of Autophagy and Exosomes on Liver Fibrosis

Du, Y., Zhu, S., Zeng, H., Wang, Z., Huang, Y., Zhou, Y., Zhang, W., Zhu, J., & Yang, C. (2023) · Current Stem Cell Research & Therapy · doi:10.2174/1574888x18666230427112930 · Cited by 5 · see citing works

Multipotent Stromal Stem Cell Approach in Alleviating Autophagy Beclin-1/XBP-1/STAT5A/PTEN Signaling Pathways in Novodrin-induced Liver Dysfunction

Kadry, M. O., & Megeed, R. M. A. (2023) · Gene Expression · doi:10.14218/ge.2023.00052 · Cited by 5 · see citing works

Human umbilical cord mesenchymal stem cells enhance liver regeneration and decrease collagen content in fibrosis mice after partial hepatectomy by activating Wnt/β-catenin signaling

Li, X., Feng, J., Cheng, H., Jin, N., Jin, S., Liu, Z., Xu, J., & Xie, J. (2024) · Acta Biochimica et Biophysica Sinica · doi:10.3724/abbs.2024207 · Cited by 5 · see citing works

Noncoding RNA-Mediated Epigenetic Regulation in Hepatic Stellate Cells of Liver Fibrosis

Gao, R., & Mao, J. (2024) · Non-Coding RNA · doi:10.3390/ncrna10040044 · Cited by 4 · see citing works

Extracellular vesicles derived from bone marrow mesenchymal stem cells ameliorate liver fibrosis via micro-7045-5p

Liu, Z., Jiang, X., You, H., Tang, Z., Ma, Y., Che, N., Liu, W., & Ma, C. (2025) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-024-05152-4 · Cited by 4 · see citing works

Astilbin Alleviates Radiation-Induced Pulmonary Fibrosis via circPRKCE Targeting the TGF-β/Smad7 Pathway to Inhibit Epithelial–Mesenchymal Transition

Shi, Z., Liu, J., Qin, J., Xian, L., Ou, X., Zhang, T., Yan, X., Hu, Q., Huang, W., & Hu, K. (2025) · Biomedicines · doi:10.3390/biomedicines13030689 · Cited by 4 · see citing works

Melatonin‐Stimulated Mesenchymal Stem Cells‐Derived Exosomes Carrying LINC00052 Alleviate Hyperoxic Lung Injury by Promoting miR‐152‐3p‐KLF4‐Nrf2 Pathway

Li, N., Fang, D., Feng, G., Zhang, L., Liu, Y., Gao, Y., & Jin, H. (2025) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.70241 · Cited by 4 · see citing works

Review of Chinese medicine intervention in PI3K/AKT pathway to regulate fibrosis

Huang, S., Zhang, Z.-C., Chen, Y., Shang, C.-J., Zhu, M., & Li, W.-H. (2025) · Medicine · doi:10.1097/md.0000000000042957 · Cited by 4 · see citing works

Endogenous Engineering Reprograms Extracellular Vesicles for Enhanced Therapeutic Function

Wang, J., Zhao, W., Hu, X., Wang, Y., Yang, P., Zheng, D., Wang, Y., L, G., Shi, M., Wei, W., et al. (2026) · Advanced Science · doi:10.1002/advs.202524231 · Cited by 4 · see citing works

Nucleic acids and proteins carried by exosomes from various sources: Potential role in liver diseases

Xie, D., Qian, B., & Li, X. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.957036 · Cited by 4 · see citing works

Mechanisms of Stem Cells and Their Secreted Exosomes in the Treatment of Autoimmune Diseases

Lin, S. J., Wang, K., Pan, X.-H., & Ruan, G. (2024) · Current Stem Cell Research & Therapy · doi:10.2174/011574888x271344231129053003 · Cited by 4 · see citing works

Nanotechnology-driven biomaterials for chronic liver diseases: Stage-specific strategies for advanced theranostics

Cai, Y., Nie, T., Luo, X., Wu, Y., & Wu, J. (2026) · Acta Biomaterialia · doi:10.1016/j.actbio.2026.01.043 · Cited by 4 · see citing works

Therapeutic potential of exosome derived from hepatocyte growth factor-overexpressing adipose mesenchymal stem cells in TGFβ1-stimulated hepatic stellate cells

Wang, J., Ye, W., Jiang, M., Zhou, Y., & Zheng, J. (2024) · Cytotechnology · doi:10.1007/s10616-023-00611-0 · Cited by 3 · see citing works

Exosomes derived from liver failure patients’ plasma stimulated mesenchymal stem cells alleviate acute liver failure

Wang, Z., Ling, J., You, S., & Zhu, B. (2025) · Stem Cell Research & Therapy · doi:10.1186/s13287-025-04163-2 · Cited by 3 · see citing works

Design, synthesis, and antitumor activity of NSDs inhibitors targeting lung squamous cell carcinoma

Xiu, S., Jia, Z., Wang, Z., Liu, H., Shi, C., Sun, X., Zhang, X., Chi, X., Liu, Z., & Zhang, L. (2025) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2025.117388 · Cited by 3 · see citing works

Anti-miR-141-3p maintains homeostasis between autophagy and apoptosis by targeting Yy1 in the fetal lumbosacral defecation center of rats

Li, Y., Liu, P., Yao, Y., Wang, W., Jia, H., Bai, Y., Yuan, Z., & Yang, Z. (2024) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2024.102163 · Cited by 3 · see citing works

Small-molecule natural products for reversing liver fibrosis based on modulation of HSCs activation: an updatePreprint

Zheng, Y., Yang, Z., Luo, K., & Li, X. (2022) · doi:10.22541/au.166542685.54449876/v1 · Cited by 2 · see citing works

Mechanisms, efficacy, and future perspectives of cellular-based therapies for liver fibrosis/cirrhosis: focusing on mesenchymal stromal cells

Pan, X., Gao, T., & Wang, B. (2025) · Cell &amp; Bioscience · doi:10.1186/s13578-025-01520-9 · Cited by 2 · see citing works

Investigating the Antifibrotic Action of Foeniculum vulgare Root Bark Volatile Oil Through the HK2/PKM2/LDHA Pathway

Ming, K., Peng, L., Pan, Y., Zhu, M., Xiao, Y., Ye, S., Xu, K., & Liu, X. (2025) · Phytotherapy Research · doi:10.1002/ptr.70050 · Cited by 2 · see citing works

Bone marrow MSCs-derived exosomes (BM-MSCs-Exo) expressed mir-181, mir-24, mir-9, mir-29, mir-338, and mir-486 ameliorated hepatic fibrosis in male rats via altering the expression of Menin-1/TGF-β/smad pathway

Khamis, T., Ibrahim, A. A. E. W., Ali, L. S., El‐Shal, A. S., Abdallah, S. H., Alanazi, A., Abdellatif, H., Salah, W., Kashgari, F. A., Halloull, N. M., et al. (2025) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2025.178209 · Cited by 2 · see citing works

Circular RNA Gsr-0002 promotes schistosomiasis-induced liver fibrosis by regulating the DNMT3A/PTEN pathway

Dai, B., Huang, S., Hu, Q., Wang, P., Gong, L., Xu, G., Wu, F., Qin, H., Xia, S., Sun, W., et al. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.148776 · Cited by 2 · see citing works

Roles of Exosome–Derived Noncoding RNA in Fibrosis

Wang, Y., Le, Z., Shi, R., & Li, K. (2025) · Molecules and Cells · doi:10.1016/j.mocell.2025.100309 · Cited by 2 · see citing works

Extracellular vesicles derived from HSCs transmitted circPVT1 to ameliorate oxidative damage to hepatocytes by targeting the miR-125b-5p/BCL2L2 signalling pathway

Wang, Y., Chang, A., Huang, Q., Ye, Z., Ding, Y., Li, C., Feng, Q., Zou, Y., Duan, S., Wang, F., et al. (2026) · Cellular Signalling · doi:10.1016/j.cellsig.2026.112405 · Cited by 2 · see citing works

The interactive role of microRNA and other non-coding RNA in hepatitis B (HBV) associated fibrogenesis

Sartorius, K., Wang, Y., Sartorius, B. K. D., Antwi, S. O., Li, X., Chuturgoon, A. A., Lu, Y., Lu, Y., & Wang, Y. (2025) · Functional & Integrative Genomics · doi:10.1007/s10142-024-01519-4 · Cited by 2 · see citing works

Therapeutic Role of Bone Marrow Mesenchymal Stem Cells (BMSCs) in Nonalcoholic Steatohepatitis (NASH) Cirrhosis

Jiang, H.-T., Ye, H.-M., Yu, H.-Y., Zhu, Y., Hu, M., He, M., Li, W., Yu, Z., Yang, Q., He, L., et al. (2024) · Current Stem Cell Research & Therapy · doi:10.2174/011574888x328447241023063825 · Cited by 1 · see citing works

Functional Recovery and Cellular Damage Mechanism of Mesoporous Silica Nanoparticles/Chitosan Solution/Methylprednisolone-collagen on Nerve Injury Caused by Ketamine Overdose

Liao, S., Huang, H., & Tang, Y. (2025) · Pharmacognosy Magazine · doi:10.1177/09731296251360081 · Cited by 1 · see citing works

Identification of miRNAs Expression Characteristics and Biomarkers in Serum‐Derived Exosomes of Wilson’s Disease Patients

Chen, H., Wang, X., Ma, Y., Pu, Y., Ye, H., & Zhang, J. (2026) · Mediators of Inflammation · doi:10.1155/mi/9097039 · Cited by 1 · see citing works

Plasma miRNA-Metabolite Dysregulation in People with HIV with Cirrhosis Despite Successful HCV Cure

Virseda‐Berdices, A., Behar-Lagares, R., Berenguer, J., González‐García, J., Requena, B., Brochado‐Kith, O., Díez, C., Hontañón, V., Grande‐García, S., González-Riaño, C., et al. (2026) · Pharmaceuticals · doi:10.3390/ph19010170 · Cited by 1 · see citing works

Mechanisms of Action and Biomarker Potential of ncRNAs in Hepatocellular Carcinoma and Liver Fibrosis: A Review

Sohn, E. J., & Oh, S.-O. (2026) · Analytical Cellular Pathology · doi:10.1155/ancp/2283163 · Cited by 1 · see citing works

Extracellular vesicles derived from live or apoptotic mesenchymal stem cells: comparison of the effects of two extracellular vesicles on liver fibrosis

Ju, R., Tian, S., Li, B., Zhang, M., Ma, S., Hu, Y., Su, R., Yang, F., Xia, E., Shang, Y., et al. (2026) · BMC Gastroenterology · doi:10.1186/s12876-026-04762-0 · Cited by 1 · see citing works

Novel Mechanistic Insights into Primary Biliary Cholangitis: From Pathogenesis to Mesenchymal Stem Cell-Mediated Repair

Huang, Z., Zhang, M., Zhang, X., Ge, Y., He, C., & Li, J. (2026) · Biomedicines · doi:10.3390/biomedicines14051101 · Cited by 1 · see citing works

Advances in mesenchymal stem cell therapy and natural antioxidants for hepatic fibrosis: A comprehensive review

Kazmi, A., & Sultana, T. (2024) · Pharmacological Research - Reports · doi:10.1016/j.prerep.2024.100016 · Cited by 1 · see citing works

The optimal dose of human umbilical-cord mesenchymal stem cells (hUC-MSCs) on hypoxic ischemic brain damage(HIBD) rats via intranasal transplantationPreprint

Yang, M., Zheng, K., Zhang, R., He, G., Xu, J., Jiang, H., Ren, L., Zhao, L., Liao, Y., Fu, Z., et al. (2024) · Research Square · doi:10.21203/rs.3.rs-4708272/v1

Enolase and 16.5‐kDa Tegument‐Associated Protein in Fasciola hepatica Extracellular Vesicles: Clues to Their Role in Pathogenesis

González, A., Sánchez‐López, C. M., Sánchez‐Palencia, L. F., Marcilla, A., & Bernal, D. (2025) · Journal of Extracellular Biology · doi:10.1002/jex2.70055

Additional file 1 of ADSCs-derived exosomes ameliorate hepatic fibrosis by suppressing stellate cell activation and remodeling hepatocellular glutamine synthetase-mediated glutamine and ammonia homeostasis

Wu, B., Feng, J., Guo, J., Wang, J., Xiu, G., Xu, J., Ning, K., Ling, B., Fu, Q., & Xu, J. (2022) · Figshare · doi:10.6084/m9.figshare.21273840

Additional file 2 of Macrophage PTEN controls STING-induced inflammation and necroptosis through NICD/NRF2 signaling in APAP-induced liver injury

Yang, T., Qu, X., Zhao, J., Wang, X., Wang, Q., Dai, J., Zhu, C., Li, J., & Jiang, L. (2023) · Figshare · doi:10.6084/m9.figshare.23590387

hMSCs-derived exosome circCDK13 inhibits liver fibrosis by regulating the expression of MFGE8 through miR-17-5p/KAT2B

Ma, J., Li, Y., Chen, M., Wang, W., Zhao, Q., He, B., Zhang, M., & Jiang, Y. (2023) · Cell Biology and Toxicology · doi:10.1007/s10565-022-09714-4 · Cited by 37 · see citing works

Bone marrow mesenchymal stem cell-originated exosomes suppress activation of hepatic stellate cells through the miR-144-3p/SLC7A11 axis

Hao, Y., Wang, R., Zhou, Q., & Ren, J. (2024) · Clinical and Experimental Hepatology · doi:10.5114/ceh.2024.142898 · Cited by 6 · see citing works

Exosomes derived from miR‐181‐5p‐modified adipose‐derived mesenchymal stem cells prevent liver fibrosis via autophagy activation

Qu, Y., Zhang, Q., Cai, X., Li, F., Ma, Z., Xu, M., & Lu, L. (2017) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13170 · Cited by 391 · see citing works

Mesenchymal stem cell-derived exosomes protect against liver fibrosis via delivering miR-148a to target KLF6/STAT3 pathway in macrophages

Tian, S., Zhou, X., Zhang, M., Cui, L., Li, B., Liu, Y., Su, R., Sun, K., Hu, Y., Yang, F., et al. (2022) · Stem Cell Research &amp; Therapy · doi:10.1186/s13287-022-03010-y · Cited by 144 · see citing works

Mesenchymal stem cell-derived exosomal miR-26a induces ferroptosis, suppresses hepatic stellate cell activation, and ameliorates liver fibrosis by modulating SLC7A11

Cao, Y., Yang, H., Huang, Y., Lu, J., Du, H., & Wang, B. (2024) · Open Medicine · doi:10.1515/med-2024-0945 · Cited by 20 · see citing works